Recent studies have provided valuable insights into the treatment and outcomes of patients with Burkitt lymphoma. One study examined the outcomes of HIV-associated BL in a cohort of patients ...
This breakthrough is expected to give rise to novel therapies against aggressive forms of cancer, such as Burkitt’s lymphoma (BL ... The antibody treatment caused the cancer cells to undergo ...
In a collaborative effort involving more than 16 institutions around the globe, researchers from Simon Fraser University's (SFU) Department of Molecular Biology and Biochemistry have refined the ...
EBV latency has been classified into three types: type I (Burkitt's lymphoma), in which only the EBV-encoded nuclear antigen (EBNA-1) is expressed; type II (nasopharyngeal carcinoma), in which ...